Last updated: 2026-09-05 05:56:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Illumina Inc. (ILMN) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $218.18, with a market capitalisation of $32.20B and a P/E ratio of 40.57. Over the past 52 weeks, its price has ranged from $88.00 to $231.81. This page covers its latest market performance, valuation, price trends and company information.
$32.20B | |
$216.74 | |
$555.77 | |
$1.94 | |
$221.66 | |
1.48M | |
-- | |
40.57 | |
$231.81 | |
$88.00 | |
-- | |
-- |
Illumina Inc. (ILMN) last closed at $221.66 as of 2026-09-05 00:01:00, unchanged from the previous close of $221.66.
During the latest regular trading session, ILMN traded between $1.94 and $555.77, with a volume of 1.48M shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, Illumina Inc. (ILMN) moved from $213.74 to $218.18, representing a gain of 2.07% ($4.44).
The stock traded between $213.22 and $222.78 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.78 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 90.5%
ILMN is currently trading at $218.18, placing it 90.5% of the way from its 52-week low of $88.00 to its 52-week high of $231.81. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 8650 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Illumina Inc. (ILMN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.